Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study-Reference-Cited by-同舟云学术

Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study

Published:2023-08 Issue: Volume:381 Page:110557
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Markuskova Lucia,Javorova Rihova Zuzana,Fazekas Tomas,Martinkovicova Anna,Havrisko Martina,Dingova Dominika,Solavova Maria,Rabarova Daria,Hrabovska Anna^ORCID

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference56 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

2. Silent hypoxaemia in COVID-19 patients;Simonson;J. Physiol.,2021

3. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: molecular pathways and potential therapeutic options;Nazerian;Int. Immunopharm.,2022

4. Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis;Karakike;Crit. Care Med.,2021

5. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study;Docherty;BMJ,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Risk of Reduced Serum Cholinesterase Activity in COVID-19 Patients Suffering From Cytokine Storm;Cureus;2024-05-16

2. Emerging significance of butyrylcholinesterase;World Journal of Experimental Medicine;2024-03-20

3. Genetic Predisposition to Elevated Levels of Circulating ADAM17 Is Associated with the Risk of Severe COVID-19;International Journal of Molecular Sciences;2023-11-01